Norgenix Pharmaceuticals LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Norgenix Pharmaceuticals LLC
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2014.
Fertility Focus has two products that it says address 85% of the causes of female infertility, and assist in earlier diagnosis and treatment: the OvuSense home-use ovulation detection and fertile period predictor and the FertiloScope, a trans-vaginal laparoscopic instrument that is designed to diagnose and treat the main physical causes of female infertility in one minimally invasive outpatient procedure.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Monitoring Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Diagnostic Imaging Equipment & Supplies